Cooperation in Turkish Market

–_004_DB9P193MB18513B5056A315ACBE9F3E87F6D82DB9P193MB1851EURP_
Content-Type: multipart/alternative;
boundary=”_000_DB9P193MB18513B5056A315ACBE9F3E87F6D82DB9P193MB1851EURP_”

–_000_DB9P193MB18513B5056A315ACBE9F3E87F6D82DB9P193MB1851EURP_
Content-Type: text/plain; charset=”iso-8859-9″
Content-Transfer-Encoding: quoted-printable

To whom it may concern,
Hope this email finds you well.

I am Pharm.Zeynep ALTUN=C7 working as Business Development Specialist from =
Asia Orphan.

As Asia Orphan, we are a pharmaceuticals company which is located in Ankara=
/T=FCrkiye. Our main line of business is to import branded pharmaceuticals =
and orphan drugs to the Turkish Ministry of Health for the Named Patient Pr=
ogram (NPP) and to licensed market in Turkey. Please find our company prese=
ntation in the attachment. In this regard, we are one of the authorized sup=
pliers of the Turkish Ministry of Health, Social Security Institution and T=
urkish Pharmacists Association for orphan drugs which have not been license=
d yet in Turkey.

We are the distributor of Pharmanovia Group (UK), Quicksilver Scientific (U=
SA), Laboratoire XO (France), Rubio (Spain), Lab CT (Italy), Biomedica Fosc=
ama Group S.p.A (Italy), BC World Pharm (S. Korea), IL-Yang (S.Korea), Kalc=
ex (Latvia), Taiwan Biotech, Pei-Li (Taiwan), Cassara (Argentina), Farmak (=
Ukraine), etc. for licensed market and for the Named Patient Program.

In this context, we are interested in directly supplying ” HYALASE 1500 I.U=
1X10 VIAL” of Wockhardt to Named Patient Program (NPP). NPP is a direct s=
upply program which is under the control of Turkish MoH. Currently, your pr=
oduct is being supplied to Turkish NPP through warehouses in Europe. Howeve=
r, as Asia Orphan, we would like to be facilitate its direct supply via the=
Named Patient Program.

This approach offers several key advantages:

* Enhanced Product Security & Tracking: Direct supply ensures full over=
sight of distribution, allowing you to monitor product movement and complia=
nce.

* Improved Market Penetration: Unlike warehouse supply, which operates =
on a per-request basis, appointing a distributor enables proactive engageme=
nt with healthcare professionals, increasing awareness of the product’s act=
ive ingredient.

* Greater Market Potential: With an authorized distributor, the product=
‘s availability and demand could be expanded significantly, benefiting both=
patients and your company.

We would appreciate the opportunity to discuss this in more detail and expl=
ore how we can collaborate to bring those products to patients in T=FCrkiye=
through this structured and transparent process.

Please feel free to contact me for any further questions. If you want, we c=
an arrange an online meeting with you .

Looking forward to hearing from you soon.

Best regards,

Pharm.Zeynep ALTUN=C7
Business Development Specialist

[cid:image001.png@01DB99AA.22162BD0]

Asia Orphan Sanayi Ticaret A.=DE.
T: +90 544 766 54 73
M: +90 553 846 93 72
S=F6=F0=FCt=F6z=FC mah. 2176.cad. Platin Tower NO:7/38
=C7ankaya/ANKARA

–_000_DB9P193MB18513B5056A315ACBE9F3E87F6D82DB9P193MB1851EURP_
Content-Type: text/html; charset=”iso-8859-9″
Content-Transfer-Encoding: quoted-printable

v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}

To whom it may=
concern,

Hope this emai=
l finds you well.

I am Pharm.Zeynep ALTUN=C7 working as Business=
Development Specialist from Asia Orphan.

As Asia Orphan, we are a pharmaceuticals compa=
ny which is located in Ankara/T=FCrkiye. Our main line
of business is to import branded pharmaceuticals and orphan drugs to the T=
urkish Ministry of Health for the Named Patient Program (NPP) and to licens=
ed market in Turkey. Please find our company presentation in the attachment=
. In this regard, we are one of
the authorized suppliers of the Turkish Ministry of Health, Social Securit=
y Institution and Turkish Pharmacists Association for orphan drugs which ha=
ve not been licensed yet in Turkey.

We are the distributor of Pharmanovia Group (U=
K), Quicksilver Scientific (USA), Laboratoire XO (France),
Rubio (Spain), Lab CT (Italy), Biomedica Foscama Group S.p.A (Italy), BC W=
orld Pharm (S. Korea), IL-Yang (S.Korea), Kalcex (Latvia), Taiwan Biotech, =
Pei-Li (Taiwan), Cassara (Argentina), Farmak (Ukraine), etc. for licensed m=
arket and for the Named Patient
Program.

In this context, we are interested in dir=
ectly supplying "
HYALASE 1500 I.U 1X10 V=
IAL" of Wockhardt
to Named Patient Program (NPP). NPP is a direct supply program which
is under the control of T=
urkish MoH. Currently, your product is being supplied to Turkish
NPP through warehouses in Europe. However, as Asia Orpha=
n, we would like to
be
facilitate its direct supply via the Named Patient Progra=
m.

This approach offers several key advantages:

E=
nhanced Product Security & Tracking: Direct supply ensures full oversig=
ht of distribution, allowing you to monitor product movement and compliance=
.

I=
mproved Market Penetration: Unlike warehouse supply, which operates on a pe=
r-request basis, appointing a distributor enables proactive engagement with=
healthcare professionals, increasing awareness
of the product’s active ingredient.

G=
reater Market Potential: With an authorized distributor, the product’=
s availability and demand could be expanded significantly, benefiting both =
patients and your company.

We woul=
d appreciate the opportunity to discuss this in more detail and explore how=
we can collaborate to bring those products to patients
in T=FCrkiye through this structured and transparent process.=

Please feel free to contact me for any further=
questions. If you want, we can arrange an online
meeting with you .

Looking forward to hearing from you soon.

Best regards,

Pharm.Zeynep ALTUN=C7

Business Development Specialist&n=
bsp;

Asia Orphan Sanayi Ticaret A.=DE.

T: +90 544 766 54 73

M: +90 553 846 93 72

S=F6=F0=FCt=F6z=FC mah. 2176.cad. Platin Tower NO:=
7/38

=C7ankaya/ANKARA

–_000_DB9P193MB18513B5056A315ACBE9F3E87F6D82DB9P193MB1851EURP_–

–_004_DB9P193MB18513B5056A315ACBE9F3E87F6D82DB9P193MB1851EURP_
Content-Type: image/png; name=”image001.png”
Content-Description: image001.png
Content-Disposition: inline; filename=”image001.png”; size=10844;
creation-date=”Thu, 20 Mar 2025 12:09:53 GMT”;
modification-date=”Thu, 20 Mar 2025 12:09:53 GMT”
Content-ID:
Content-Transfer-Encoding: base64
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